| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 04/04/2001 | EP1088486A2 Stable powder compositions comprising vitamins and/or carotenoids and their preparation |
| 04/04/2001 | EP1087991A1 Prodrugs of dipeptidyl peptidase iv inhibitors |
| 04/04/2001 | EP1087978A1 Use of diazepins for preparing medicines for treating pathological conditions or diseases involving one of the growth hormone release inhibiting factor receptors |
| 04/04/2001 | EP1087971A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087970A1 PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS |
| 04/04/2001 | EP1087964A1 N-benzodioxanylmethyl-1-piperidyl-methylamine compounds having affinity for 5-ht receptors |
| 04/04/2001 | EP1087963A1 Inhibitors of glycogen synthase kinase 3 |
| 04/04/2001 | EP1087961A1 Phenoxylpropanolamines, method for the production thereof and pharmaceutical compositions containing the same |
| 04/04/2001 | EP1087946A1 Aryl alkanoylpyridazines |
| 04/04/2001 | EP1087943A1 Therapeutic biaryl derivatives |
| 04/04/2001 | EP1087934A1 Aminocyclohexyl ether compounds and uses thereof |
| 04/04/2001 | EP1087784A1 Synthetic somatostatin immunogen for growth promotion in farm animals |
| 04/04/2001 | EP1087779A2 Compositions for increasing energy in vivo |
| 04/04/2001 | CN1290266A Benzofuran-4-carboxamides and their therapeutical use |
| 04/04/2001 | CN1290258A Arylpiperazines having activity at the serotnin 1A receptor |
| 04/04/2001 | CN1290168A Inhibition of membrane-associated viral replication |
| 04/04/2001 | CN1290160A Pharmaceutical composition comprising combination of metformin and fibrate, and its use for treatment of hyperglycemia |
| 04/04/2001 | CN1289727A Slow-releasing phosphate glass nutritive agent and its preparing process |
| 04/04/2001 | CN1289610A Chinese patent medicine (Tangshenkang) for treating diabetes and nephrosis and its preparing process |
| 04/04/2001 | CN1289609A Chinese patent medicine (Tangweiping) for treating eyeground affection of diabetes |
| 04/04/2001 | CN1289606A Preparing process for powdered medicine for reducing blood fat |
| 04/04/2001 | CN1289596A Tonic oligofructose salt as oral liquid |
| 04/04/2001 | CN1289594A Method for treatment of diseases concerned with cytoplasmic factor |
| 04/04/2001 | CN1289548A Chewing gum for supplementing calcium and taking tooth care and its preparing process |
| 04/04/2001 | CN1063942C Use of thiazolidine derivative for making medicaments |
| 04/03/2001 | US6211393 Radicals linked to si are si--o--c, si--s--c or si--n--c type bonds and are hydrolyzable in vivo, forming si--oh bonds that are biologically active especially when in contact with living tissue |
| 04/03/2001 | US6211368 Hydrolysis of corresponding ester |
| 04/03/2001 | US6211361 Oxidation, reduction of hymenin |
| 04/03/2001 | US6211234 Substituted phenyl compounds |
| 04/03/2001 | US6211222 Substituted indazole derivatives and related compounds |
| 04/03/2001 | US6211208 2-aminopyridines containing fused ring substituents |
| 04/03/2001 | US6211207 Pharmaceutical composition |
| 04/03/2001 | US6211206 Pharmaceutical composition |
| 04/03/2001 | US6211205 Pharmaceutical composition |
| 04/03/2001 | US6211194 Solution containing nicotine |
| 04/03/2001 | US6211186 Polyoxyalkylene glycol modified with n-heterocycle derivative with amidine or guanidine group; diaper rash, obesity, acne, periodontal disease, contraceptives; protease and lipase inhibitors |
| 04/03/2001 | US6211169 Stable calcitriol solution for packaging into vials |
| 04/03/2001 | US6211167 Arylsulfonanilide phosphates |
| 04/03/2001 | US6211147 Method of promoting angiogenesis using relaxin |
| 04/03/2001 | US6210890 Human peroxisomal thioesterase |
| 04/03/2001 | US6210682 Immunization against rotavirus infection or rotavirus disease by administering to a subject a peptide nsp4 114-135, a peptide nsp4 120-147, or a toxoid thereof are disclosed. |
| 04/03/2001 | CA2188147C Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 03/30/2001 | CA2321379A1 Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors |
| 03/29/2001 | WO2001021812A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | WO2001021795A2 Fatty acid transport proteins |
| 03/29/2001 | WO2001021660A1 Peptides for combating the autoantibodies that are responsible for dilatative cardiomyopathy (dcm) |
| 03/29/2001 | WO2001021642A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 03/29/2001 | WO2001021628A1 A substantially cell membrane impermeable compound and use thereof |
| 03/29/2001 | WO2001021604A1 Substituted piperazine derivatives, the production thereof and their use as inhibitors of the microsomal triglyceride-transfer protein (mtp) |
| 03/29/2001 | WO2001021602A1 Oxa- and thiazole derivatives useful as antidiabetic and antiobesity agents |
| 03/29/2001 | WO2001021600A1 Caspase inhibitor |
| 03/29/2001 | WO2001021598A1 Therapeutic quinazoline compounds |
| 03/29/2001 | WO2001021591A1 Pyrazole derivatives |
| 03/29/2001 | WO2001021589A2 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 03/29/2001 | WO2001021587A2 Hydroxyfunctional amide 1h-indole derivatives active as spla2 inhibitors |
| 03/29/2001 | WO2001021584A1 Tyrosine derivatives |
| 03/29/2001 | WO2001021583A1 Hydroxamic acid derivatives, process for the production thereof and drugs containing the same as the active ingredient |
| 03/29/2001 | WO2001021582A1 Biphenyl derivatives used as nhe-3 inhibitors |
| 03/29/2001 | WO2001021578A1 O-anisamide derivatives |
| 03/29/2001 | WO2001021575A1 Anti-inflammatory nitro- and thia- fatty acids |
| 03/29/2001 | WO2001021259A2 Use and compositions for treating platelet-related disorders using anagrelide |
| 03/29/2001 | WO2001021205A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/29/2001 | WO2001021204A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | WO2001021182A1 Physical strength enhancing agents and glycogen accumulation promoting agents |
| 03/29/2001 | WO2001021172A1 Anti-cancer nitro- and thia-fatty acids |
| 03/29/2001 | WO2001021163A2 Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents |
| 03/29/2001 | WO2001021159A2 Pharmaceutical composition of nateglinide and another antidiabetcagent |
| 03/29/2001 | WO2001021156A1 Pharmaceutical chewing gum formulations |
| 03/29/2001 | WO2001020969A2 Use of ribose to prevent cramping and soreness in muscles |
| 03/29/2001 | WO2000075139A3 Benzothiazinone and benzoxazinone compounds |
| 03/29/2001 | WO2000073294A3 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides |
| 03/29/2001 | WO2000037487A8 αvβ6 INTEGRIN INHIBITORS |
| 03/29/2001 | WO2000012741A9 Inducible expression system |
| 03/29/2001 | DE19946289A1 Benzodiazepin-Derivate, deren Herstellung und Anwendung Benzodiazepine derivatives, their production and use |
| 03/29/2001 | DE19945594A1 Substituierte Piperazinderivate, ihre Herstellung und ihre Verwendung als Arzneimittel Substituted piperazine derivatives, their preparation and their use as medicaments |
| 03/29/2001 | DE19945302A1 Biphenylderivate als NHE-3-Inhibitoren Biphenyl as NHE-3 inhibitors |
| 03/29/2001 | CA2387529A1 Biphenyl derivatives as nhe-3 inhibitors |
| 03/29/2001 | CA2385552A1 Phosphatases which activate map kinase pathways |
| 03/29/2001 | CA2385447A1 Pyrazole derivatives |
| 03/29/2001 | CA2385445A1 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use |
| 03/29/2001 | CA2385105A1 Mono- and bis-indolylquinones and prophylactic and therapeutic uses thereof |
| 03/29/2001 | CA2383598A1 Therapeutic uses of m3 polypeptide |
| 03/29/2001 | CA2383152A1 Agent for enhancing stamina and agent for promoting glycogen accumulation |
| 03/29/2001 | CA2382547A1 Methods and compositions for treating platelet-related disosders |
| 03/29/2001 | CA2369515A1 Pharmaceutical chewing gum formulations |
| 03/29/2001 | CA2350700A1 Coupling factor 6 inhibitor and potentiator and use thereof |
| 03/28/2001 | EP1086249A2 Diagnostic method based on quantification of extramitochondrial dna |
| 03/28/2001 | EP1086225A2 Human tumour-derived polypeptide hormone phosphatonin |
| 03/28/2001 | EP1086212A2 Method and reagents for the treatment of diseases or conditions related to molecules involved in angiogenic responses |
| 03/28/2001 | EP1086137A1 Composition and method for modulating dendritic cell-t cell interaction |
| 03/28/2001 | EP1086131A1 Cyclic somatostatin analogs |
| 03/28/2001 | EP1086130A1 Insulin analogue |
| 03/28/2001 | EP1086129A1 Anti-angiogenic proteins and methods of use thereof |
| 03/28/2001 | EP1086113A2 Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use |
| 03/28/2001 | EP1086108A1 Heterobicyclic and tricyclic nitric oxide synthase inhibitors |
| 03/28/2001 | EP1086106A1 Furopyridine derivatives and their therapeutical use |
| 03/28/2001 | EP1086101A1 Beta-carboline compounds |
| 03/28/2001 | EP1086098A1 Thienyl substituted acylguanidines as inhibitors of bone resorption and vitronectin receptor antagonists |
| 03/28/2001 | EP1086092A1 BENZO(b)THIEPINE-1,1-DIOXIDE DERIVATIVES, A METHOD FOR THE PRODUCTION THEREOF, MEDICAMENTS CONTAINING THESE COMPOUNDS, AND THEIR USE |
| 03/28/2001 | EP1086086A1 Imidazolyl derivatives and their use as somatostatin receptor ligands |